Nvidia among investors in xAI’s $20 bln capital raise- Bloomberg
Robert Ainscow, Chief Operating Officer of ASP Isotopes Inc (NASDAQ:ASPI), sold 8,438 shares of common stock on September 8, 2025, for a total of $71944. The shares were sold at a price of $8.5263, close to the current trading price of $8.37. The stock has shown remarkable performance, delivering a 232% return over the past year, though InvestingPro analysis indicates the stock is slightly overvalued at current levels.
On September 9, 2025, Ainscow also exercised options to acquire 150,000 shares at $0.25, 12,000 shares at $2.00 and 135,000 shares at $2.00, for a total of $331500.
On the same day, Ainscow disposed of 4,396 shares, 2,813 shares and 31,652 shares for $331484. The price per share was $8.53.
Following these transactions, Ainscow directly owns 1,669,693 shares of ASP Isotopes Inc, representing a significant stake in the company, which currently has a market capitalization of $781 million.
In other recent news, ASP Isotopes Inc. has been involved in several significant developments. The company announced a Memorandum of Understanding with Fermi America to explore the development of a High Assay Low Enriched Uranium (HALEU) enrichment facility in Carson County, Texas. This planned facility aims to enhance domestic nuclear fuel production and reduce reliance on Russian sources. Additionally, ASP Isotopes and its subsidiary, Quantum Leap Energy LLC, are set to form a joint venture with Fermi America to produce HALEU for small modular reactors at the HyperGrid campus near Amarillo, Texas. In corporate governance, Ralph L. Hunter has joined the ASP Isotopes board of directors and the board of managers of Quantum Leap Energy LLC, bringing over 30 years of nuclear industry experience. Furthermore, ASP Isotopes has invested $5 million in seed funding into IsoBio, Inc., supporting their development of antibody-isotope conjugates for cancer treatment. These recent developments underscore ASP Isotopes’ strategic initiatives in both nuclear fuel production and medical isotope technology.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.